Dana Lynch | Director of Corporate Communications & Corporate Affairs |
Peter Greenleaf | President & Chief Executive Officer |
Joe Miller | Chief Financial Officer |
Max Colao | Chief Commercial Officer |
Neil Solomons | Chief Medical Officer |
Olivia Brayer | Cantor Fitzgerald |
Maury Raycroft | Jeffries |
Stacy Ku | Cowen and Company |
Ed Arce | HC Wainwright |
Sahil Dhingra | RBC |
David Martin | Bloom Burton |
Justin Kim | Oppenheimer |
Greetings, and welcome to the Aurinia Pharmaceuticals First Quarter 2022 Financial and Operational Results Conference Call. At this time all participants are in a listen-only mode and a question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Dana Lynch, Aurinia's Senior Director of Corporate Communications and Corporate Affairs. Thank you.